Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of obesity ...
Weight loss drugs linked to dozens of deaths - The medical director of the NHS has warned of the side effects of weight loss ...
With the rise of obesity drugs a pair of Penn State researchers set out to answer a question: could drugs aimed at weight ...
Eli Lilly was second to the lucrative GLP-1 market for diabetes and obesity following its chief metabolic medicine rival Novo ...
There’s evidence that the demographic of people on the drugs overlaps with those who like to spend, a group some analysts ...
We recently published a list of Top 10 Stocks to Buy According to Sustainable Insight Capital Management. In this article, we ...
Eli Lilly's stock offers high growth potential, driven by GLP-1 therapies and strong R&D efforts. Read why LLY stock is ...
Sustainable Insight Capital Management (SICM) focuses on institutional investments, offering both long-only and long-short strategies in public equities.
David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous ...
If you have diabetes, drinking alcohol can affect your blood sugar. Remember, Mounjaro is approved to help manage blood sugar in adults with type 2 diabetes. So drinking alcohol can make Mounjaro not ...
Eli Lilly & Co. said Thursday that its Type 2 diabetes drug Mounjaro and its weight-loss and diabetes drug Zepbound drove a 45% increase in fourth-quarter revenue to $13.53 billion. The drugmaker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results